hrcak mascot   Srce   HID

Pregledni rad

Current knowledge about prostatic cancer a proposal for a common therapy protocol

Rudjer Novak
Antun Tucak
Krešimir Glavina
Domagoj Glavina

Puni tekst: engleski, pdf (4 MB) str. 31-38 preuzimanja: 50* citiraj
APA 6th Edition
Novak, R., Tucak, A., Glavina, K. i Glavina, D. (1991). Current knowledge about prostatic cancer a proposal for a common therapy protocol. Medicinski vjesnik, 23 ((1-2)), 31-38. Preuzeto s https://hrcak.srce.hr/195821
MLA 8th Edition
Novak, Rudjer, et al. "Current knowledge about prostatic cancer a proposal for a common therapy protocol." Medicinski vjesnik, vol. 23, br. (1-2), 1991, str. 31-38. https://hrcak.srce.hr/195821. Citirano 22.06.2021.
Chicago 17th Edition
Novak, Rudjer, Antun Tucak, Krešimir Glavina i Domagoj Glavina. "Current knowledge about prostatic cancer a proposal for a common therapy protocol." Medicinski vjesnik 23, br. (1-2) (1991): 31-38. https://hrcak.srce.hr/195821
Harvard
Novak, R., et al. (1991). 'Current knowledge about prostatic cancer a proposal for a common therapy protocol', Medicinski vjesnik, 23((1-2)), str. 31-38. Preuzeto s: https://hrcak.srce.hr/195821 (Datum pristupa: 22.06.2021.)
Vancouver
Novak R, Tucak A, Glavina K, Glavina D. Current knowledge about prostatic cancer a proposal for a common therapy protocol. Medicinski vjesnik [Internet]. 1991 [pristupljeno 22.06.2021.];23((1-2)):31-38. Dostupno na: https://hrcak.srce.hr/195821
IEEE
R. Novak, A. Tucak, K. Glavina i D. Glavina, "Current knowledge about prostatic cancer a proposal for a common therapy protocol", Medicinski vjesnik, vol.23, br. (1-2), str. 31-38, 1991. [Online]. Dostupno na: https://hrcak.srce.hr/195821. [Citirano: 22.06.2021.]
Puni tekst: hrvatski, pdf (4 MB) str. 31-38 preuzimanja: 149* citiraj
APA 6th Edition
Novak, R., Tucak, A., Glavina, K. i Glavina, D. (1991). Današnje spoznaje o karcinomu prostate - prijedlog za zajednički koncept terapije. Medicinski vjesnik, 23 ((1-2)), 31-38. Preuzeto s https://hrcak.srce.hr/195821
MLA 8th Edition
Novak, Rudjer, et al. "Današnje spoznaje o karcinomu prostate - prijedlog za zajednički koncept terapije." Medicinski vjesnik, vol. 23, br. (1-2), 1991, str. 31-38. https://hrcak.srce.hr/195821. Citirano 22.06.2021.
Chicago 17th Edition
Novak, Rudjer, Antun Tucak, Krešimir Glavina i Domagoj Glavina. "Današnje spoznaje o karcinomu prostate - prijedlog za zajednički koncept terapije." Medicinski vjesnik 23, br. (1-2) (1991): 31-38. https://hrcak.srce.hr/195821
Harvard
Novak, R., et al. (1991). 'Današnje spoznaje o karcinomu prostate - prijedlog za zajednički koncept terapije', Medicinski vjesnik, 23((1-2)), str. 31-38. Preuzeto s: https://hrcak.srce.hr/195821 (Datum pristupa: 22.06.2021.)
Vancouver
Novak R, Tucak A, Glavina K, Glavina D. Današnje spoznaje o karcinomu prostate - prijedlog za zajednički koncept terapije. Medicinski vjesnik [Internet]. 1991 [pristupljeno 22.06.2021.];23((1-2)):31-38. Dostupno na: https://hrcak.srce.hr/195821
IEEE
R. Novak, A. Tucak, K. Glavina i D. Glavina, "Današnje spoznaje o karcinomu prostate - prijedlog za zajednički koncept terapije", Medicinski vjesnik, vol.23, br. (1-2), str. 31-38, 1991. [Online]. Dostupno na: https://hrcak.srce.hr/195821. [Citirano: 22.06.2021.]

Sažetak
General frequency of prostatic cancer (including incidental and undetected) outnumbers clinical prostatic cancer, although this one is by far the most frequent cancer of man. Current diagnosis of clinical prostatic cancer is based on digital examination, rectal ultrasound, serum prostatic specific antigen level and transrectal biopsy. Modern classification has to separate localized from advanced and disseminated disease. A high percent age of prostatic cancer is inactive disease whose mortality does not outnumber the man lethality without cancer. Today, we have some concrete factors indicating the disease aggressive potential, e.g. regional lymph node growth, high PSA and PAP levels, primary tumor size, high grading and nuclear aneuploidy. With them, the cases requiring therapy can be differentiated from those with inactive cancer. Localized aggressive prostatic cancer with general conditions for operation fulfilled indicates radical prostatectomy. The advanced and disseminated disease is an indication for paliative therapy, which is based on complete androgen deprivation. This is achieved in the first phase of therapy with orchydectomy + GnLH analogues + antiandrogens. The next therapeutic phase (after new disease progression ) consists of phosphorilized stilbens, such as Estracyt and Honvan. The final, exclusively symptomatic therapy should be preceded by chemotherapy.

Ključne riječi
prostatic cancer

Hrčak ID: 195821

URI
https://hrcak.srce.hr/195821

[hrvatski]

Posjeta: 282 *